Concepedia

Anastasia Parton

AP

10

Publications

998

Citations

10

H-Index

1994

Active since

Affiliations

Bristol-Myers Squibb (Switzerland)(Current)

Anastasia Parton is an author at Bristol-Myers Squibb (Switzerland) specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

1994–2022

10

Publications

10

Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity

Peter Schäfer, Anastasia Parton, Lori Capone et al. · Cellular Signalling · 2014 · 302 citations · Full text

Dexamethasone Synergizes with Lenalidomide to Inhibit Multiple Myeloma Tumor Growth, But Reduces Lenalidomide-Induced Immunomodulation of T and NK Cell Function

Anita K. Gandhi, Jingfen Kang, Lori Capone et al. · Current Cancer Drug Targets · 2010 · 167 citations

, , +18

Absorption, metabolism and excretion of [14C]pomalidomide in humans following oral administration

Matthew Hoffmann, Claudia Kasserra, Josephine Reyes et al. · Cancer Chemotherapy and Pharmacology · 2012 · 120 citations · Full text

Phosphodiesterase 4 in inflammatory diseases: Effects of apremilast in psoriatic blood and in dermal myofibroblasts through the PDE4/CD271 complex

Peter Schäfer, Francesca Truzzi, Anastasia Parton et al. · Cellular Signalling · 2016 · 119 citations · Full text

Lenalidomide inhibits proliferation of Namalwa CSN.70 cells and interferes with Gab1 phosphorylation and adaptor protein complex assembly

Anita K. Gandhi, Jian Kang, S. Naziruddin et al. · Leukemia Research · 2006 · 95 citations

, , +6

Rows per page

1–5 of 10